• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cara Therapeutics Inc

+ Add to Watchlist

CARA:US

8.1800 USD 0.4200 5.41%

As of 20:10:00 ET on 10/23/2014.

Snapshot for Cara Therapeutics Inc (CARA)

Open: 7.8100 Day's Range: 7.7600 - 8.2500 Volume: 41,148
Previous Close: 7.7600 52wk Range: 7.5300 - 23.2500 1-Yr Rtn: -

Stock Chart for CARA

No chart data available.
  • CARA:US 8.2000
  • 1D
  • 1M
  • 1Y
7.7600
Interactive CARA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CARA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0550
Est. EPS (USD) (12/2014) -0.8300
Est. PEG Ratio -
Market Cap (M USD) 185.23
Shares Outstanding (M) 22.64
30 Day Average Volume 83,699
Price/Book (mrq) 3.0086
Price/Sale (ttm) 15.2676
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CARA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CARA

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Derek ChalmersPresident/CEO/Co-FounderJosef C SchoellChief Financial Officer
Robert A MedveChief Medical OfficerFrederique MenzaghiVP:R&D/Co-Founder
More Company Profile & Key Executives for CARA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil